Ads
related to: multiple sclerosis treatment
Search results
MMJ to Summons DEA Heads - Milgram DEA Director Removed from Marijuana Rescheduling Issue
Morningstar· 5 days agoMarijuana Rescheduling Process Normally Steered by the DEA had been taken over by the U.S. Justice Department. The decision would not be signed by DEA ANNE MILGRAM but by Attorney General Merrick Garland. WASHINGTON, DC / ACCESSWIRE / May 23, 2024 /
Pre-Tax Cannabis Benefits & Reduced Copays: How CannaPlan Optimizes Healthcare With Opioid...
Benzinga· 6 days agoRising healthcare costs and employee retention are pressing concerns for all businesses across the...
The Week’s 10 Biggest Funding Rounds: Scale AI’s Massive $1B Deal Leads Slower Week
Crunchbase· 4 days agoWant to keep track of the largest startup funding deals in 2024 with our curated list of $100...
Click Therapeutics picks up Better's app assets in diabetes, obesity
FierceBiotech· 6 days agoMedical app developer Click Therapeutics will increase its digital reach by obtaining assets from...
Biogen to buy Peninsula startup developing a drug for kidney disease for $1.2 billion - San...
The Business Journals· 6 days agoBiogen Inc. is shelling out $1.15 billion upfront to buy HI-Bio, a South San Francisco immunology...
FSD Pharma Provides Corporate Update
Digital Journal· 1 day agoTORONTO, ON / ACCESSWIRE / May 24, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of ...
Biogen to buy San Francisco startup developing a drug for kidney disease for $1.2B - Boston Business...
The Business Journals· 6 days agoBiogen Inc. is shelling out $1.15 billion upfront to buy a South San Francisco immunology company....
Spinal cord treatment restores function for paralyzed patients in study: ‘New hope’
Fox News· 7 days agoAfter receiving spinal cord simulation from ONWARD Medical’s ARC-EX system, the participants saw...
How do I manage functional visual loss - Eye
Nature· 6 days agoThere is consensus that patient’s confidence in the diagnosis of FND and motivation to engage with rehabilitation therapy is essential for successful treatment [18]. Conversely ...
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by Russell Investments Group Ltd.
ETF DAILY NEWS· 6 days agoRussell Investments Group Ltd. trimmed its position in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 6.8% in the fourth quarter, according to its most recent disclosure with the Securities ...
